Traditional Chinese medical composition for treating infant eczema

Abstract

The invention relates to a traditional Chinese medical composition for treating infant eczema. The traditional Chinese medical composition for treating infant eczema is prepared from the traditional Chinese medicinal materials in parts by weight: 5-10 parts of radix sophorae flavescentis, 3-5 parts of Scutellaria baicalensis, 5-10 parts of Chinese Tamarisk Twig, 3-8 parts of fructus cnidii, 3-6 parts of jasmine, 3-5 parts of Ligusticum wallichii, 6-9 parts of Schizonepeta, 8-12 parts of cortex dictamni, 3-6 parts of radix stemonae, 5-15 parts of chrysanthemum, 3-6 parts of honeysuckle, 3-10 parts of periostracum cicada, 8-12 parts of fructus kochiae, 8-12 parts of folium eriobotryae, 3-6 parts of Paris polyphylla, 8-12 parts of rhizoma atractylodis and 2-5 parts of liquorice. The medicine provided by the invention has the effects of clearing away heat and drying dampness, invigorating the circulation of blood and removing swelling and dispelling wind and arresting itching, is mild in drug property and free from hormone, irritation and grease and convenient to use, and is easily accepted by infants and parents.

Description

technical field [0001] The invention relates to a medicine for treating eczema, in particular to a Chinese medicinal composition prepared from Chinese herbal medicines for treating eczema. Background technique [0002] Eczema in infants and young children is a common clinical disease, commonly known as "tinea milk" and "ringworm of fetus", characterized by various types of itchy rash, erythema, papules, scales, lichenification and exudation; Suffering, lingering and difficult to heal, and easy to relapse, make children emotionally disturbed and affect sleep and diet, and secondary bacterial infection, hindering normal growth and health. The current treatment of this disease generally adopts the prevention and treatment method of oral administration and external application. Because it is difficult to choose medication for infants and young children, external medications often contain glucocorticoids or histamine antiallergic drugs in clinical practice, which can easily lead ...

AI Technical Summary

Problems solved by technology

[0002] Eczema in infants and young children is a common clinical disease, commonly known as "tinea milk" and "ringworm of fetus", characterized by various types of itchy rash, erythema, papules, scales, lichenification and exudation; Suffering, lingering and difficult to heal, and easy to relapse, making children emotionally disturbed and affecting sleep and eating, and secondary bacterial infection, hindering normal growth and health

The current treatment of this disease generally adopts the prevention and treatment method of oral administration and external application. Because it is difficult to choose medication for infants and young children, external medications often contain glucocorticoids or histamine antiallergic drugs in clinical practice, which can easily lead to systemic or local adverse reactions. , resulting in passive resistance of parents, poor treatment effect, inventing a green drug with no side effects has become a clinical problem to be solved urgently